Background and Purpose: The relation of poststroke blood pressure to stroke recurrence remains undetermined, and the optimal control of blood pressure has not been established. We 
A ntihypertensive therapy is a general recommendation for stroke survivors with hypertension to reduce stroke recurrence.' 2 Many, but not all, studies have demonstrated that antihypertensive therapy effectively reduces cardiovascular morbidity, mortality, and stroke recurrence.3-8 A potential benefit of antihypertensive therapy is to prevent further progression of pathological changes in the brain vessels.9-12 A decrease in blood pressure (BP), however, may reduce cerebral blood flow (CBF) in patients with impaired cerebral autoregulation and with hemodynamically compromised brain tissues, potentially causing recurrent ischemic events. '3-17 Recent studies in hypertensive patients with vascular complications or in elderly patients demonstrated that lowering BP reduces cardiovascular morbidity and mortality, but an excessive drop in BP may paradoxically increase cardiovascular complications. [18] [19] [20] [21] [22] [23] [24] [25] The relation of diastolic BP with the incidence of cardiac events provides a J-shaped curve with a nadir at approximately 85 mm Hg, representing a complex effect of BP on cardiovascular events. [26] [27] [28] [29] No studies have confirmed a similar relation for stroke recurrence.
In the present study, we evaluated retrospectively the effect of poststroke BP on stroke recurrence. We also determined the effects of stroke subtypes, age, and antihypertensive treatment on the BP-stroke recurrence rate curves.
Subjects and Methods
We performed the present study on 368 consecutive hypertensive patients (266 men, 102 women; mean age, 62 years) with brain infarction, transient ischemic attack (TIA), and brain hemorrhage who were admitted within 3 months after stroke onset and observed for at least 6 months at the Cerebrovascular Division, National Cardiovascular Center, Japan, during the period from 1982 to 1986. Their observation period was 6 to 96 months, with an average of 38 months.
Patients were classified into the following stroke subtypes: (1) brain hemorrhage, (2) atherothrombotic brain infarction (ATBI), (3) lacunar brain infarction (LBI), (4) .0 mm Hg) quartile had significantly higher recurrence rates than those in the second quartile, again demonstrating the J-curve phenomenon. The J-curve phenomenon in poststroke DBP was not obvious in patients with brain hemorrhage (Fig 3A) . Brain hemorrhage patients with lower poststroke DBP had less frequent recurrence. In subset analysis of patients with ATBI and LBI, the J point in poststroke DBP was higher in the former than in the latter ( Fig  3B) .
Comparisons of baseline clinical features among the four patient subgroups classified by poststroke DBP revealed that patients' age was not the same among the four subgroups (P<.01, one-way analysis of variance; Table 2 ). The stroke recurrence rates were not significantly different between patients with and without antihypertensive agents. Subgroup analysis of the relation between stroke recurrence rate and poststroke DBP levels demonstrated that the J-curve phenomenon was noted both in patients with and without antihypertensive treatment (Table 3) . Other baseline characteristics, including stroke subtype at entry, male-to-female ratio, other major risk factors of stroke (diabetes mellitus, hyperlipidemia, ischemic heart disease, arrhythmia, prior stroke, etc), and frequency of antiplatelet and anticoagulant treatment were almost the same among the subgroups. History of ischemic heart disease, including myocardial infarction and angina pectoris, did not increase stroke recurrence rate (9.1% per patient-year in 49 patients with ischemic heart disease versus 7.2% in 319 without ischemic heart disease; P=NS) or affect the J-curve phenomenon. Both groups experienced the lowest stroke recurrence rate at the DBP range of 80 to 84 mm Hg.
To clarify the interaction between SBP and DBP, we classified patients into three groups according to poststroke SBP, then determined the relations of poststroke DBP to stroke recurrence rate in each group. In every group, stroke recurrence rate was the lowest in patients with poststroke DBP of 80 to 84 mm Hg and demonstrated a J-shaped curve (Table 3) In the present study, the J-curve phenomenon was observed in patients with brain infarction but not in those with brain hemorrhage. The J point was higher in patients with ATBI than in patients with LBI. These results suggest that hypertensive patients with ATBI were particularly vulnerable to low poststroke DBP. The lower limit of autoregulation of CBF shifts to a higher level of BP in hypertensive than in normotensive subjects, so that only mild hypotension or normalization of BP may induce a decrease in CBF.'3 Hemodynamically compromised brain tissues in some patients with ATBI are theoretically vulnerable to a decrease in systemic BP, although effects of chronic hemodynamic failure on stroke recurrence remain unknown. '4,37 38 These pathophysiological mechanisms may be responsible for a paradoxical increase in stroke recurrence rate at the lower poststroke DBP.
Dependency of coronary circulation on DBP but not on SBP is the most likely explanation for the presence of the J-curve phenomenon only for DBP in ischemic heart disease. In contrast, both SBP and DBP have a relation to tissue perfusion in the brain. In the Framingham Study, the probability of occurrence of a brain infarction was predicted by SBP and DBP level.39 Therefore, not only DBP but also SBP may have a J-curve relation to stroke recurrence, although our data did not support this speculation. DBP may be more important than SBP in determining perfusion pressure and blood flow in the brain. This concept is supported by recent observations with ultrasonography demonstrating that the diastolic intravascular blood flow and velocity to the brain were kept at a higher level than those to other organs. [40] [41] [42] Because of the retrospective nature of the study, we could not adjust patients' age and control the use of antihypertensive agents. We found that patients with a poststroke DBP of less than 80 mm Hg were the oldest among the patient subgroups classified by ranges of poststroke DBP, which is in common with a hypertensive population.43.44 Stroke recurrence rate was higher in patients older than 65 years than in the younger patients over all ranges of poststroke DBP. Marquardsen33 suggested that advancing age is accompanied by an increase in stroke recurrence, but this aging effect was absent in other studies.3' Previous studies demonstrated that the J-curve phenomenon for myocardial infarction was consistently observed even in elderly hypertensive patients.24,25,45 We could not determine the net effects of poststroke DBP, independent of aging, on stroke recurrence, although similar J-curve trends in both the younger (younger than 65 years) and older (65 years or older) patient subgroups were observed, even in age subgroups classified by 10-year intervals, suggesting that the J-curve phenomenon is independent of an aging effect.
Patients treated with antihypertensive drugs were most frequently in the highest poststroke DBP range. In some patients, DBP dropped spontaneously without medication. Both patients with antihypertensive medication and those without medication exhibited the J-curve phenomenon. A previous study reported that the J-curve phenomenon for myocardial infarction was dependent on DBP level but not on antihypertensive medication. 27 In ischemic heart disease, subclinical myocardial damage may cause hypotension that precedes symptomatic events. However, we cannot apply this possibility to stroke occurrence. Sutton-Tyrrell et a146 reported recently that among patients with isolated systolic hypertension, low DBP is a marker for carotid stenosis. This observation may in part explain the relation between the low poststroke DBP and an increase in stroke recurrence rate in the present study, although we could not find an inverse correlation of DBP with stroke recurrence rate among the isolated systolic hypertension group but did confirm the J-curve even in patients with LBI.
Prior intervention studies have consistently confirmed the beneficial effects of antihypertensive treatment on stroke occurrence in young patients with severe arterial hypertension but not in older patients or patients with milder hypertension.3-8 Many factors, including stroke subtypes, hemodynamic state in the brain, age, baseline BP level, and degree and speed of decrease in BP, may influence recurrence in hypertensive stroke patients. Well-controlled prospective studies are needed to determine the optimal control levels of poststroke BP in each stroke subtype for preventing recurrent stroke.-
